❓ Mr. Whitely's question seeks detailed information on the referral pathways, client demographics, diagnoses, and medication usage at the Joondalup and Murdoch Complex Attention and Hyperactivity Disorders Services. The answer refers to another question, suggesting a possible duplication or related inquiry.
AnsweredQoN 5658Legislative Assembly
QuestionView source ↗
In relation to the Joondalup and Murdoch Complex Attention and Hyperactivity Disorders Services:
(a) what are the referral pathways by which clients access these services;
(b) when did each service begin servicing clients;
(c) what is the number, age and gender demographic of clients seen at each service;
(d) by service and age and sex demographic, what is the number of clients who, when first seen by the service:
(i) had a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD); and/or
(ii) had other discrete and co-morbid disorders (please specify individual disorders; and
(iii) were treated with:
(A) dexamphetamine; and/or
(B) methylphenidate; and/or
(C) atomoxetine; and/or
(D) other psychotropic drugs; and
(e) what is the number, age and sex demographic of clients who, six months after their initial visit:
(i) had a diagnosis of ADHD; and/or
(ii) had other discrete and co-morbid disorders (please specify individual disorders); and
(iii) were treated with:
(A) dexamphetamine; and/or
(B) methylphenidate; and/or
(C) atomoxetine; and/or
(D) other psychotropic drugs?
(a) what are the referral pathways by which clients access these services;
(b) when did each service begin servicing clients;
(c) what is the number, age and gender demographic of clients seen at each service;
(d) by service and age and sex demographic, what is the number of clients who, when first seen by the service:
(i) had a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD); and/or
(ii) had other discrete and co-morbid disorders (please specify individual disorders; and
(iii) were treated with:
(A) dexamphetamine; and/or
(B) methylphenidate; and/or
(C) atomoxetine; and/or
(D) other psychotropic drugs; and
(e) what is the number, age and sex demographic of clients who, six months after their initial visit:
(i) had a diagnosis of ADHD; and/or
(ii) had other discrete and co-morbid disorders (please specify individual disorders); and
(iii) were treated with:
(A) dexamphetamine; and/or
(B) methylphenidate; and/or
(C) atomoxetine; and/or
(D) other psychotropic drugs?
AnswerView source ↗
Answered
6 September 2011
Responded by
Minister representing the Minister for Mental Health; Disability Services
Response time
84 days
Please see Legislative Council Question on Notice 5657.
Notice: This document is created or edited using unregistered or evaluation copy of rtLib valid for testing or development purposes only. To use it for productive or any other purposes please register it. You may purchase the license on
http://www.rtlib.com
Notice: This document is created or edited using unregistered or evaluation copy of rtLib valid for testing or development purposes only. To use it for productive or any other purposes please register it. You may purchase the license on
http://www.rtlib.com
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.